Meridian Corp Earnings Per Share Disclosure
| Year Ended December 31, | |||||||||||
| (dollars in thousands, except per share data) | 2025 | 2024 | |||||||||
| Numerator for earnings per share: | |||||||||||
| Net income available to common stockholders | $ | 21,836 | $ | 16,346 | |||||||
| Denominators for earnings per share: | |||||||||||
| Weighted average shares outstanding | 11,446 | 11,260 | |||||||||
| Average unearned ESOP shares | (120) | (147) | |||||||||
| Basic weighted average shares outstanding | 11,326 | 11,113 | |||||||||
| Dilutive effects of assumed exercises of stock options | 212 | 130 | |||||||||
| Diluted weighted average shares outstanding | 11,538 | 11,243 | |||||||||
| Basic earnings per share | $ | 1.93 | $ | 1.47 | |||||||
| Diluted earnings per share | $ | 1.89 | $ | 1.45 | |||||||
| Antidilutive shares excluded from computation of average dilutive earnings per share | 502 | 603 | |||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 13, 2026 | Showing above |
| 2024 | Mar 17, 2025 | |
| 2023 | Mar 15, 2024 | |
| 2022 | Mar 16, 2023 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.